Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions.

Lienhardt C, Lönnroth K, Menzies D, Balasegaram M, Chakaya J, Cobelens F, Cohn J, Denkinger CM, Evans TG, Källenius G, Kaplan G, Kumar AM, Matthiessen L, Mgone CS, Mizrahi V, Mukadi YD, Nguyen VN, Nordström A, Sizemore CF, Spigelman M, Squire SB, Swaminathan S, Van Helden PD, Zumla A, Weyer K, Weil D, Raviglione M.

PLoS Med. 2016 Mar 2;13(3):e1001965. doi: 10.1371/journal.pmed.1001965. eCollection 2016 Mar.

2.

False Alarms, Pseudoepidemics, and Reality: A Case Study with American College of Obstetricians and Gynecologists Practice Bulletins.

Chauhan SP, Hammad IA, Weyer KL, Ananth CV.

Am J Perinatol. 2016 Apr;33(5):442-8. doi: 10.1055/s-0035-1566247. Epub 2015 Nov 2.

PMID:
26523741
3.

Comparative test of ecological assessment methods of lowland streams based on long-term monitoring data of macrophytes.

Wiegleb G, Gebler D, van de Weyer K, Birk S.

Sci Total Environ. 2016 Jan 15;541:1269-81. doi: 10.1016/j.scitotenv.2015.10.005. Epub 2015 Nov 11.

PMID:
26476066
4.

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR Jr, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M.

Eur Respir J. 2015 Dec;46(6):1563-76. doi: 10.1183/13993003.01245-2015. Epub 2015 Sep 24.

5.

Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs.

Barrera L, Cooreman E, de Dieu Iragena J, Drobniewski F, Duda P, Havelkova M, Hoffner S, Kam KM, Kim SJ, Labelle S, Lambregts K, Leimane V, Nunn P, Ramsay A, Raviglione M, Rich M, Ridderhof J, Rodrigues F, Rüsch-Gerdes S, Salfinger M, Scholten J, Selvakumar N, Shinnick T, Shul'gina M, Šķenders G, Sloutsky A, Small P, Van Deun A, Varaine F, Yagui M, Vincent V, Weyer K, Wright A, Zignol M.

Geneva: World Health Organization; 2008.

6.

Institutional Tuberculosis Transmission. Controlled Trial of Upper Room Ultraviolet Air Disinfection: A Basis for New Dosing Guidelines.

Mphaphlele M, Dharmadhikari AS, Jensen PA, Rudnick SN, van Reenen TH, Pagano MA, Leuschner W, Sears TA, Milonova SP, van der Walt M, Stoltz AC, Weyer K, Nardell EA.

Am J Respir Crit Care Med. 2015 Aug 15;192(4):477-84. doi: 10.1164/rccm.201501-0060OC.

PMID:
25928547
7.

Discovery, innovation, and new frontiers in tuberculosis diagnostics: reflections and expectations.

Weyer K.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S78-80. doi: 10.1093/infdis/jiu822. Review. No abstract available.

8.

Defining the needs for next generation assays for tuberculosis.

Denkinger CM, Kik SV, Cirillo DM, Casenghi M, Shinnick T, Weyer K, Gilpin C, Boehme CC, Schito M, Kimerling M, Pai M.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S29-38. doi: 10.1093/infdis/jiu821. Review.

9.

Tuberculosis control: hard questions.

Weyer K, Falzon D, Wares F, Jaramillo E, Raviglione M.

Lancet. 2014 Nov 15;384(9956):1744. doi: 10.1016/S0140-6736(14)62065-1. Epub 2014 Nov 14. No abstract available.

PMID:
25455240
10.

Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation.

Migliori GB, Lienhardt C, Weyer K, van der Werf MJ, Blasi F, Raviglione MC.

Eur Respir J. 2014 Dec;44(6):1412-7. doi: 10.1183/09031936.00132114. No abstract available.

PMID:
25435528
11.

Multidrug-resistant tuberculosis around the world: what progress has been made?

Falzon D, Mirzayev F, Wares F, Baena IG, Zignol M, Linh N, Weyer K, Jaramillo E, Floyd K, Raviglione M.

Eur Respir J. 2015 Jan;45(1):150-60. doi: 10.1183/09031936.00101814. Epub 2014 Sep 26.

12.

Papp-a2 modulates development of cranial cartilage and angiogenesis in zebrafish embryos.

Kjaer-Sorensen K, Engholm DH, Jepsen MR, Morch MG, Weyer K, Hefting LL, Skov LL, Laursen LS, Oxvig C.

J Cell Sci. 2014 Dec 1;127(Pt 23):5027-37. doi: 10.1242/jcs.152587. Epub 2014 Sep 18.

13.

Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.

Gao S, Hein S, Dagnæs-Hansen F, Weyer K, Yang C, Nielsen R, Christensen EI, Fenton RA, Kjems J.

Theranostics. 2014 Aug 13;4(10):1039-51. doi: 10.7150/thno.7866. eCollection 2014.

14.

Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.

Bastos ML, Hussain H, Weyer K, Garcia-Garcia L, Leimane V, Leung CC, Narita M, Penã JM, Ponce-de-Leon A, Seung KJ, Shean K, Sifuentes-Osornio J, Van der Walt M, Van der Werf TS, Yew WW, Menzies D; Collaborative Group for Meta-analysis of Individual Patient Data in MDR-TB.

Clin Infect Dis. 2014 Nov 15;59(10):1364-74. doi: 10.1093/cid/ciu619. Epub 2014 Aug 5.

15.

Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies.

Hwang TJ, Dotsenko S, Jafarov A, Weyer K, Falzon D, Lunte K, Nunn P, Jaramillo E, Keshavjee S, Wares DF.

BMJ Open. 2014 Jan 2;4(1):e004143. doi: 10.1136/bmjopen-2013-004143. Review.

16.

Drug-resistant tuberculosis: latest advances.

Falzon D, Weyer K, Raviglione MC.

Lancet Respir Med. 2013 Mar;1(1):e9-e10. doi: 10.1016/S2213-2600(12)70056-5. Epub 2013 Jan 14. No abstract available.

PMID:
24321818
17.

The authors reply.

Nielsen R, Weyer K, Birn H, Christensen EI.

Kidney Int. 2013 Nov;84(5):1050-1. doi: 10.1038/ki.2013.326. No abstract available.

PMID:
24172740
18.

Increased lysosomal proteolysis counteracts protein accumulation in the proximal tubule during focal segmental glomerulosclerosis.

Nielsen R, Mollet G, Esquivel EL, Weyer K, Nielsen PK, Antignac C, Christensen EI.

Kidney Int. 2013 Nov;84(5):902-10. doi: 10.1038/ki.2013.218. Epub 2013 Jun 12.

PMID:
23760285
19.

Linezolid for extensively drug-resistant tuberculosis.

Jaramillo E, Weyer K, Raviglione M.

N Engl J Med. 2013 Jan 17;368(3):290. doi: 10.1056/NEJMc1214183#SA1. No abstract available.

PMID:
23323917
20.

Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis.

Pantoja A, Fitzpatrick C, Vassall A, Weyer K, Floyd K.

Eur Respir J. 2013 Sep;42(3):708-20. doi: 10.1183/09031936.00147912. Epub 2012 Dec 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk